Skip to main content
Donate

FAST is the largest funder of Angelman syndrome research harnessing the power of science to make life better for individuals living with Angelman syndrome. Our strength lies in our sole focus to cure Angelman syndrome. Founded by parents determined to find a cure for their children living with Angelman syndrome, FAST has become a powerhouse in the scientific community, funding more than $50 million in Angelman syndrome-specific research.

When you give, you are funding research to cure Angelman syndrome. Make a one-time gift today, set up a recurring monthly donation or explore other ways you can give to FAST.

Donate online here.

Many corporations will match their employee gifts to charitable organizations, effectively doubling or tripling your personal gift to FAST. Ask your employer if they have a matching gifts program or look up your company with our search tool." Also, add the search tool to this page!

Or give another way! A few options:

Send a Check

Simply make checks out to the Foundation for Angelman Syndrome Therapeutics and send them to our mailing address.

Mailing Address: PO Box 40307 Austin, TX 78704

Make a Tribute Gift

A tribute gift to FAST is a unique and meaningful way to honor someone dear to you or to memorialize the passing of an individual who has touched your life. When you make a tribute gift, the individual or family of the loved one whom you are honoring or memorializing can be notified of your thoughtfulness with a personalized acknowledgment, if requested. You can make a tribute gift online or contact Elizabeth directly at elizabeth@cureangelman.org for more information.

IRA Charitable Rollover

If you are 70 ½ or older, a charitable gift transferred directly from your IRA to FAST will not be taxed and will qualify toward your required minimum distribution. Simply provide your administrator with our legal name, address and federal tax ID.

  • Legal name: Foundation for Angelman Syndrome Therapeutics

  • Mailing Address: PO Box 40307, Austin, TX 78704

  • Federal Tax ID: 26-3160079

For specific questions, please contact your financial advisor.

Gifts of Stock

Donating appreciated securities, including stocks or bonds, is an easy and tax-effective way for you to make a gift to FAST. You get an income tax deduction for the full fair market value of securities you have owned for more than one year—subject to the usual limitations—and capital gains taxes will be completely avoided on these assets.

To transfer securities, please contact: elizabeth.oconnor@cureangelman.org

Estate Gifts

If you have included or are considering including a gift to FAST through your estate plan, we’d love to hear from you. Conversations about gift designations, honoring a loved one, and recognition options are encouraged, all to ensure the donor's wishes and legacy are understood and fulfilled. Naming FAST as a beneficiary of a will or trust is one of the easiest ways for donors to leave a legacy, ensuring your support of Angelman syndrome research for years to come. You can make a bequest to FAST by including language in your will or living trust leaving a portion of your estate to FAST or by designating FAST as a beneficiary of your retirement account or life insurance policy.

Donor Advised Fund

A donor-advised fund (DAF) is a charitable giving vehicle that you can create to manage charitable donations on behalf of yourself and your loved ones. DAFs allow you to support FAST while receiving favorable tax benefits and having the ability to recommend grants from the fund over time. To direct a gift to FAST from your donor advised fund, simply share our legal name, address and federal tax ID.

  • Legal name: Foundation for Angelman Syndrome Therapeutics

  • Mailing Address: PO Box 40307, Austin, TX 78704

  • Tax ID: 26-3160079

Give Through a Private Foundation

FAST actively seeks private foundations to partner with to advance our aggressive research agenda. We serve as a liaison between grantmaking foundations and FAST. The philanthropic support provided by private foundations helps ensure the research is funded so that potential treatments can move into current medical practice as quickly as possible.

Corporate Partnerships

FAST actively seeks new opportunities and welcomes your company’s involvement in our mission. We can work with you on innovative campaigns to help raise awareness of Angelman syndrome research while helping you meet your corporate social responsibility objectives.

Through a partnership with FAST, your company can help lead the way in Angelman syndrome research and showcase your trust in our mission. From cause marketing to corporate giving to event sponsorship and employee engagement, we can help you find the best way to make the biggest impact.

For more information, contact elizabeth.oconnor@cureangelman.org.

Many corporations will match their employee gifts to charitable organizations, effectively doubling or tripling your personal gift to FAST. Ask your employer if they have a matching gifts program or look up your company with our search tool.

Double Your Donation!

Matching Gift and Volunteer Grant information provided by
Powered by Double the Donation

Angelman Syndrome News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.